2,3-dimethylmaleic anhydride has been researched along with Benign Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, Y; Li, C; Li, L; Sun, K; Zhang, P | 1 |
| Hoang, NH; Jung, CE; Lee, ES; Lim, C; Oh, KT; Sim, T; Youn, YS | 1 |
| Dai, HB; Luo, L; Maruf, A; Nurhidayah, D; Sun, D; Wang, GX; Wang, JX; Wang, Y; Wu, W; Zhang, XJ; Zhong, Y | 1 |
| Cao, J; Huang, X; Liu, T; Yan, H; Zhang, Y | 1 |
4 other study(ies) available for 2,3-dimethylmaleic anhydride and Benign Neoplasms
| Article | Year |
|---|---|
In vitro/vivo antitumor study of modified-chitosan/carboxymethyl chitosan "boosted" charge-reversal nanoformulation.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carbohydrate Sequence; Chitosan; Dendrimers; Doxorubicin; Drug Carriers; Drug Liberation; Endocytosis; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Lysosomes; Male; Maleic Anhydrides; Mice, Inbred BALB C; Necrosis; Neoplasms; Polyamines; Xenograft Model Antitumor Assays | 2021 |
A charge-reversible nanocarrier using PEG-PLL (-
Topics: Animals; Chlorophyllides; Drug Carriers; Female; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; KB Cells; Maleic Anhydrides; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Polyesters; Polyethylene Glycols; Polylysine; Porphyrins | 2017 |
Acid-Activated Melittin for Targeted and Safe Antitumor Therapy.
Topics: Acids; Animals; Antineoplastic Agents; Biocompatible Materials; Cell Survival; Chromatography, High Pressure Liquid; Drug Delivery Systems; HeLa Cells; Hemolysis; Humans; Hydrogen-Ion Concentration; Larva; Maleic Anhydrides; Melitten; Neoplasms; Proton Magnetic Resonance Spectroscopy; Reproducibility of Results; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Zebrafish | 2018 |
Polyethylenimine modified with 2,3-dimethylmaleic anhydride potentiates the antitumor efficacy of conventional chemotherapy.
Topics: Animals; Antineoplastic Agents; Cell Membrane Permeability; Cell Survival; Doxorubicin; Endocytosis; Female; Humans; Hydrogen-Ion Concentration; L-Lactate Dehydrogenase; Maleic Anhydrides; MCF-7 Cells; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Polyethyleneimine; Static Electricity | 2019 |